Cargando…
Achieving equal and timely access to innovative anticancer drugs in the European Union (EU): summary of a multidisciplinary CECOG-driven roundtable discussion with a focus on Eastern and South-Eastern EU countries
The Central European Cooperative Oncology Group (CECOG) and ‘ESMO Open—Cancer Horizons’ roundtable discussion brought together stakeholders from several European Union (EU) countries involved in drug development, drug authorisation and reimbursement or otherwise affected by delayed and unequal acces...
Autores principales: | Wilking, Nils, Bucsics, Anna, Kandolf Sekulovic, Lidlija, Kobelt, Gisela, Laslop, Andrea, Makaroff, Lydia, Roediger, Alexander, Zielinski, Christoph |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6863652/ https://www.ncbi.nlm.nih.gov/pubmed/31798977 http://dx.doi.org/10.1136/esmoopen-2019-000550 |
Ejemplares similares
-
EU MECI: A Network-Structured Indicator for a Union of Equality
por: Lapatinas, Athanasios, et al.
Publicado: (2023) -
The EU Health Union in Search of a Definition and an Open Discussion
por: Sipiczki, Agnes, et al.
Publicado: (2021) -
EuCAPT discussion
por: Bertone, Gianfranco
Publicado: (2022) -
CECOG educational illustrations: the blood–brain barrier and its relevance for targeted cancer therapies and immuno-oncology
por: Preusser, Matthias, et al.
Publicado: (2017) -
Creation of equal-spin triplet superconductivity at the Al/EuS interface
por: Diesch, S., et al.
Publicado: (2018)